Literature DB >> 35378641

Comment on "The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study".

George S Stoyanov1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35378641     DOI： 10.1007/s11060-022-04000-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  2 in total

1.  The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study.

Authors:  Andres Ramos-Fresnedo; Michael W Pullen; Carlos Perez-Vega; Ricardo A Domingo; Oluwaseun O Akinduro; Joao P Almeida; Paola Suarez-Meade; Lina Marenco-Hillembrand; Mark E Jentoft; Bernard R Bendok; Daniel M Trifiletti; Kaisorn L Chaichana; Alyx B Porter; Alfredo Quiñones-Hinojosa; Terence C Burns; Sani H Kizilbash; Erik H Middlebrooks; Wendy J Sherman
Journal:  J Neurooncol       Date:  2022-02-17       Impact factor: 4.506

2.  cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2018-09-26       Impact factor: 17.088
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.